Thoracic aortic aneurysm echocardiography or ultrasound
|
Thoracic aortic aneurysm Microchapters |
|
Differentiating Thoracic Aortic Aneurysm from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Special Scenarios |
|
Case Studies |
|
Thoracic aortic aneurysm echocardiography or ultrasound On the Web |
|
FDA on Thoracic aortic aneurysm echocardiography or ultrasound |
|
CDC on Thoracic aortic aneurysm echocardiography or ultrasound |
|
Thoracic aortic aneurysm echocardiography or ultrasound in the news |
|
Blogs on Thoracic aortic aneurysm echocardiography or ultrasound |
|
Directions to Hospitals Treating Thoracic aortic aneurysm echocardiography or ultrasound |
|
Risk calculators and risk factors for Thoracic aortic aneurysm echocardiography or ultrasound |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Mohammad Salih, MD.
Overview
The diagnosis of a thoracic aortic aneurysm is often made as an incidental finding on transthoracic echocardiography (dilated aortic root) or on trans esophageal echocardiography (enlarged ascending aorta or aortic arch). The definitive diagnosis is made using CT angiography but MRA is also an excellent test. Once diagonosed, serial CTA (or MRA) are recommended every 6-12 months.
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients with Thoracic Aortic Disease (DO NOT EDIT)[1]
Determining the Presence and Progression of Thoracic Aortic Disease (DO NOT EDIT)[1]
| Class I |
| "1. For measurements taken by echocardiography, the internal diameter should be measured perpendicular to the axis of blood flow. For aortic root measurements the widest diameter, typically at the mid-sinus level, should be used. (Level of Evidence: C)" |
Genetic Syndromes (DO NOT EDIT)[1]
| Class I |
| "1. An echocardiogram is recommended at the time of diagnosis of Marfan syndrome to determine the aortic root and ascending aortic diameters (see(Figure 5))and 6 months thereafter to determine the rate of enlargement of the aorta. (Level of Evidence: C)" |
| "2. Annual imaging is recommended for patients with Marfan syndrome if stability of the aortic diameter is documented. If the maximal aortic diameter is 4.5 cm or greater, or if the aortic diameter shows significant growth from baseline, more frequent imaging should be considered (Level of Evidence: C)" |
References
- ↑ 1.0 1.1 1.2 Hiratzka LF, Bakris GL, Beckman JA; et al. (2010). "2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM guidelines for the diagnosis and management of patients with Thoracic Aortic Disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, American Association for Thoracic Surgery, American College of Radiology, American Stroke Association, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of Thoracic Surgeons, and Society for Vascular Medicine". Circulation. 121 (13): e266–369. doi:10.1161/CIR.0b013e3181d4739e. PMID 20233780. Unknown parameter
|month=ignored (help)